We narrowed to 144 results for: GFP expression plasmids

1. pAAV-CAG-GFP (AAV6 trial size)

   Viral Prep

   #37825-AAV6.T

   Purpose

   Ready-to-use AAV6 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available since

   July 16, 2025

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CAG-GFP (AAV1 trial size)

   Viral Prep

   #37825-AAV1.T

   Purpose

   Ready-to-use AAV1 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-CAG-GFP (AAV2 trial size)

   Viral Prep

   #37825-AAV2.T

   Purpose

   Ready-to-use AAV2 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-CAG-GFP (AAV11 trial size)

   Viral Prep

   #37825-AAV11.T

   Purpose

   Ready-to-use AAV11 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available since

   July 16, 2025

   Availability

   Academic Institutions and Nonprofits only

5. pENN.AAV.CAG.Flex.GFPsm_myc.WPRE.SV40 (AAV1)

   Viral Prep

   #98927-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pENN.AAV.CAG.Flex.GFPsm_myc.WPRE.SV40 (#98927). In addition to the viral particles, you will also receive purified pENN.AAV.CAG.Flex.GFPsm_myc.WPRE.SV40 plasmid DNA. CAG-driven, Cre-dependent expression of GFPsm_myc spaghetti monster construct. Spaghetti monster constructs are not fluorescent ("dark") to allow full range of antibody staining. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger

   Article

   Viswanathan et al Nat Methods. 2015 Jun;12(6):568-76. doi:

   Promoter

   CAG

   Tags

   GFPsm-myc (spaghetti monster construct)

   Available since

   June 12, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-CAG-GFP (AAV MaCPNS1)

   Viral Prep

   #37825-MaCPNS1

   Purpose

   Ready-to-use AAV MaCPNS1 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV were produced with the MaCPNS1 serotype, which permits efficient transduction of the PNS in rodents and the CNS and PNS (including ENS) in marmosets and rhesus macaques. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available since

   Nov. 9, 2023

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-hSyn-EGFP (AAV Retrograde)

   Viral Prep

   #50465-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. Synapsin-driven EGFP-expression control. These AAV preparations are suitable purity for injection into animals. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   EGFP

   Available since

   Oct. 19, 2017

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-CaMKIIa-EGFP (AAV Retrograde)

   Viral Prep

   #50469-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   CaMKII

   Tags

   EGFP

   Available since

   Sept. 13, 2021

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-CaMKIIa-EGFP (AAV PHP.eB)

   Viral Prep

   #50469-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   CaMKII

   Tags

   EGFP

   Available since

   Feb. 16, 2024

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-EF1α1.1-GFP (AAV2)

    Viral Prep

    #122100-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-EF1α1.1-GFP (#122100). In addition to the viral particles, you will also receive purified pAAV-EF1α1.1-GFP plasmid DNA. EF1a-driven expression of GFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

    Promoter

    EF1a（1.1kb short version)

    Tags

    GFP

    Available since

    Aug. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-hSyn-DIO-EGFP (AAV8)

    Viral Prep

    #50457-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP (Cre-dependent)

    Available since

    Jan. 26, 2021

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-hSyn-EGFP (AAV1 trial size)

    Viral Prep

    #50465-AAV1.T

    Purpose

    Ready-to-use AAV1 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP

    Available since

    July 12, 2019

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-hSyn-EGFP (AAV9 trial size)

    Viral Prep

    #50465-AAV9.T

    Purpose

    Ready-to-use AAV9 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP

    Available since

    May 29, 2019

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-hSyn-EGFP (AAV2 trial size)

    Viral Prep

    #50465-AAV2.T

    Purpose

    Ready-to-use AAV2 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP

    Available since

    July 31, 2019

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-hSyn-DIO-EGFP (AAV2)

    Viral Prep

    #50457-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP (Cre-dependent)

    Available since

    Jan. 17, 2020

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-hSyn-DIO-EGFP (AAV1)

    Viral Prep

    #50457-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP (Cre-dependent)

    Available since

    Feb. 18, 2020

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-hSyn-DIO-EGFP (AAV5)

    Viral Prep

    #50457-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP (Cre-dependent)

    Available since

    July 8, 2019

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-hSyn-EGFP (AAV5 trial size)

    Viral Prep

    #50465-AAV5.T

    Purpose

    Ready-to-use AAV5 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP

    Available since

    June 12, 2019

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-hSyn-EGFP (AAV8 trial size)

    Viral Prep

    #50465-AAV8.T

    Purpose

    Ready-to-use AAV8 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP

    Available since

    May 29, 2019

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-hSyn-EGFP (AAV11 trial size)

    Viral Prep

    #50465-AAV11.T

    Purpose

    Ready-to-use AAV11 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP

    Available since

    July 16, 2025

    Availability

    Academic Institutions and Nonprofits only